Healthcare provider profile · identity verified

Lee Yarber

Nurse Practitioner · WINSTON SALEM, NC · NPI 1417592080

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	233	35
Atorvastatin Calcium	Atorvastatin Calcium	216	34
Amlodipine Besylate	Amlodipine Besylate	207	32
Pantoprazole Sodium	Pantoprazole Sodium	185	30
Gabapentin	Gabapentin	170	29
Furosemide	Furosemide	152	33
Eliquis	Apixaban	147	20
Trazodone Hcl	Trazodone Hcl	137	25
Losartan Potassium	Losartan Potassium	115	16
Spironolactone	Spironolactone	99	17
Memantine Hcl	Memantine Hcl	96	13
Oxycodone Hcl	Oxycodone Hcl	96	33
Sertraline Hcl	Sertraline Hcl	90	16
Potassium Chloride	Potassium Chloride	89	13
Torsemide	Torsemide	89	20
Carvedilol	Carvedilol	86	13
Rosuvastatin Calcium	Rosuvastatin Calcium	85	14
Duloxetine Hcl	Duloxetine Hcl	73	20
Tramadol Hcl	Tramadol Hcl	73	22
Escitalopram Oxalate	Escitalopram Oxalate	69	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	69	14
Donepezil Hcl	Donepezil Hcl	67	suppressed
Omeprazole	Omeprazole	67	12
Metoprolol Succinate	Metoprolol Succinate	65	11
Metformin Hcl	Metformin Hcl	64	13
Hydralazine Hcl	Hydralazine Hcl	62	14
Metoprolol Tartrate	Metoprolol Tartrate	60	suppressed
Lorazepam	Lorazepam	59	22
Tamsulosin Hcl	Tamsulosin Hcl	58	suppressed
Famotidine	Famotidine	57	13
Clopidogrel	Clopidogrel Bisulfate	55	suppressed
Lisinopril	Lisinopril	54	suppressed
Ondansetron Odt	Ondansetron	54	13
Levetiracetam	Levetiracetam	52	suppressed
Mirtazapine	Mirtazapine	47	12
Hydrochlorothiazide	Hydrochlorothiazide	46	12
Methocarbamol	Methocarbamol	46	13
Pregabalin	Pregabalin	45	15
Simvastatin	Simvastatin	45	suppressed
Prednisone	Prednisone	44	16
Ezetimibe	Ezetimibe	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	17
Pravastatin Sodium	Pravastatin Sodium	42	suppressed
Trulicity	Dulaglutide	40	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	39	suppressed
Divalproex Sodium	Divalproex Sodium	37	17
Midodrine Hcl	Midodrine Hcl	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Jardiance	Empagliflozin	32	suppressed
Latanoprost	Latanoprost	31	suppressed
Nystatin	Nystatin	31	22
Albuterol Sulfate Hfa	Albuterol Sulfate	30	18
Metformin Hcl Er	Metformin Hcl	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Tradjenta	Linagliptin	29	suppressed
Finasteride	Finasteride	28	suppressed
Irbesartan	Irbesartan	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Ramipril	Ramipril	27	suppressed
Gemtesa	Vibegron	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Allopurinol	Allopurinol	25	suppressed
Baclofen	Baclofen	25	suppressed
Rivastigmine	Rivastigmine Tartrate	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Memantine Hcl Er	Memantine Hcl	22	suppressed
Cephalexin	Cephalexin	21	16
Doxycycline Hyclate	Doxycycline Hyclate	21	17
Alprazolam	Alprazolam	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Lacosamide	Lacosamide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Amiloride Hcl	Amiloride Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Repaglinide	Repaglinide	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	suppressed
Amantadine	Amantadine Hcl	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Nyamyc	Nystatin	15	11
Restasis	Cyclosporine	15	suppressed
Risperidone	Risperidone	15	suppressed
Silodosin	Silodosin	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Estradiol	Estradiol	14	suppressed
Hydroxyurea	Hydroxyurea	14	suppressed
Linzess	Linaclotide	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error